CorestemChemon (KOSDAQ: 166480) is entering a critical late-stage phase in the commercialization of its ALS stem cell therapy, Neuronata-R. The company attributes this momentum to advanced domestic ...
The assays were shipped to ALS Global in Moncton New Brunswick for preparation with final analysis of pulps conducted in Vancouver, British Columbia. The primary analytical method for the Wedge ...
Grays Harbor Fire District #1 is now providing basic life services transportation services for Oakville residents ...
I like the fact that this city seems to love me," Isreal Hagan once said of Syracuse. "I love it, and it loves me right back.
What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...
The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
A new rapid blood test for ALS has been announced by the not-for-profit Brain Chemistry Labs in Jackson Hole. Based on ...
ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...
Researchers examined rope cords and caulking material to determine the age of the fabled Hjortspring plank boat to narrow ...
Faced with a bleak prognosis of ALS, 35-year-old Megan Decker, along with her husband, Joey, "want to make as many memories as possible with our children while mommy is still here." ...
Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback